PENCIL BIOSCIENCES
Pencil Biosciences aims to develop a novel, programmable genome-modulation tool that overcomes the challenges associated with the technologies currently available.
PENCIL BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Alderley Park, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pencilbiosciences.com
Total Employee:
1+
Status:
Active
Contact:
01625704040
Total Funding:
673.67 K USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Varnish Mobile Optimized
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Raven biosciences
Raven biosciences is a contract research provider based in Denmark.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
O2h Ventures
O2h Ventures investment in Seed Round - Pencil Biosciences
GM&C Life Sciences Fund
GM&C Life Sciences Fund investment in Seed Round - Pencil Biosciences
Jonathan Milner
Jonathan Milner investment in Seed Round - Pencil Biosciences
Future Planet Capital
Future Planet Capital investment in Seed Round - Pencil Biosciences
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - Pencil Biosciences
Official Site Inspections
http://www.pencilbiosciences.com
- Host name: webcluster2.webpod16-cph3.one.com
- IP address: 46.30.215.99
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Pencil Biosciences"
pencilbiosciences.com
Next Generation Genome Editing Tool. Pencil Biosciences is developing a truly innovative gene editing technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases โฆSee details»
Pencil Biosciences - Crunchbase Company Profile
Pencil Biosciences is a novel gene modulation company. Pencil Biosciences may be growing as it has been identified as a developer of gene-editing technology, which is a field that has been receiving significant attention and investment.See details»
PENCIL BIOSCIENCES LIMITED overview - Find and update โฆ
PENCIL BIOSCIENCES LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business โฆSee details»
Pencil Biosciences - Overview, News & Similar companies
Sep 28, 2023 Popular Searches Pencil Biosciences Ltd Pencil Biosciences Pencilbiosciences SIC Code 87,873 NAICS Code 54,541 Show more. Similar Companies to Pencil Biosciences. โฆSee details»
PENCIL BIOSCIENCES LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PENCIL BIOSCIENCES LIMITED of MACCLESFIELD. Get the latest business insights from Dun & โฆSee details»
Pencil Biosciences Limited - LinkedIn
Pencil Biosciences Limited | 1,722 followers on LinkedIn. Developing the Next Generation Gene Editing Technology | Pencil Biosciences is developing a truly innovative gene modulation โฆSee details»
Pencil Biosciences - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Pencil Biosciences. Use the PitchBook Platform to explore the full profile.See details»
PENCIL BIOSCIENCES LIMITED - VentureRadar
Similar Companies: Epigenic Therapeutics China Privately Held Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy โฆSee details»
Pencil Biosciences raises £5.6M to advance gene โฆ
Sep 28, 2023 UK-based gene editing and modulation tech startup Pencil Biosciences has raised £5.6 million in Seed funding. Designed to assist the transformation of the gene editing landscape in therapeutic solutions for those โฆSee details»
Pencil Biosciences completes fundraise to develop โฆ
Sep 29, 2023 Pencil Biosciences was founded in 2019 by Dr Rajik Ibrahim, Dr Timothy Schulz-Utermoehl and Dr Martin Quibell. Now led by CEO Dr Amanda Smith, primary Founder and CTO Dr Rajik Ibrahim and Chair Dr Jon Moore, โฆSee details»
Pencil Biosciences - Craft
Pencil Biosciences is a bioengineering company developing a gene modulation technology. It can have an impact across a range of applications, including therapeutic options for patients with โฆSee details»
Pencil Biosciences - Company Profile - Tracxn
Nov 17, 2024 Pencil Biosciences is a provider of gene-editing technology. It is developing an innovative gene modulation technology that can have an impact across a range of โฆSee details»
Northern Gritstone invests in Pencil Biosciences, developer of โฆ
Sep 28, 2023 Northern Gritstone has invested in Pencil Biosciences, the developer of a novel gene modulation technology based on a next generation platform which aims to transform the โฆSee details»
Pencil Biosciences - Products, Competitors, Financials, Employees ...
Pencil Biosciences is focused on developing a fully synthetic, next-generation gene editing technology within the biotechnology sector. Use the CB Insights Platform to explore Pencil โฆSee details»
Pencil Biosciences completes fundraise to develop novel gene โฆ
Oct 2, 2023 Contact Us. Binder House. 7 Narborough Wood Park. Desford Road. Enderby. Leicester. LE19 4XT. T: 0116 238 8200 EmailSee details»
Investors write £5.6m cheque to Pencil Biosciences - UKTN
Sep 28, 2023 To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow โฆSee details»
£5.6m funding to sharpen Pencilโs gene-editing tech - BusinessCloud
Oct 2, 2023 MedTech Investment. A MedTech company behind gene-editing technology has raised £5.6 million in seed financing. Pencil Biosciences is developing a fully synthetic gene โฆSee details»
Pencil Biosciences Secures £5.6 Million Funding for ... - Medium
Jul 18, 2024 Pencil Biosciences, a UK-based gene editing and modulation tech startup, has secured an impressive £5.6 million in Seed funding to advance its groundbreaking non โฆSee details»
o2h Ventures continues to back Pencil Biosciences in its £5.6M โฆ
Sep 29, 2023 Cambridge, UK: Pencil Biosciences, an innovative gene editing and modulation technology company has successfully raised £5.6 million in seed funding; a company that o2h โฆSee details»
o2h ventures makes an investment in Pencil Biosciences a novel โฆ
Cambridge, UK, 15 Feb 2020: The o2h Therapeutics and AI Fund (โThe Fundโ), an early stage S/EIS fund investing in biotechnology therapeutics and related AI opportunities, is pleased to โฆSee details»